Designing multi-targeted agents: An emerging anticancer drug discovery paradigm-Reference-Cited by-同舟云学术

Designing multi-targeted agents: An emerging anticancer drug discovery paradigm

Published:2017-08 Issue: Volume:136 Page:195-211
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Fu Rong-geng,Sun Yuan,Sheng Wen-bing,Liao Duan-fang

Funder

Natural Science Foundation of Hunan Province

Research Fund of the Pharmaceutical Science Key Discipline in the Hunan Province

International Cooperation of Chinese Medicine

Scientific Research Fund of Hunan Provincial Education Department

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference85 articles.

1. Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors;Dienstmann;Mol. Cancer. Ther.,2014

2. Kinase and BET inhibitors together clamp inhibition of PI3K signaling and overcome resistance to therapy;Stratikopoulos;Cancer. Cell.,2015

3. Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer;Guan;Invest. New. Drugs,2013

4. Combination therapy in combating cancer;Mokhtari;Oncotarget,2017

5. Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma;Mondello;Oncotarget,2017

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy;European Journal of Medicinal Chemistry;2024-11

2. HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids;European Journal of Medicinal Chemistry;2024-11

3. Gliotoxin triggers cell death through multifaceted targeting of cancer-inducing genes in breast cancer therapy;Computational Biology and Chemistry;2024-10

4. Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents;Bioorganic Chemistry;2024-10

5. Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies;Journal of Hematology & Oncology;2024-09-04